Laurie B. Keating
Board Member
Immuneering Corp (IMRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Laurie B. Keating
Laurie B. Keating is recorded as Board Member at Immuneering Corp (IMRX). Laurie B. Keating was last confirmed as Board Member at PepGen Inc. (PEPG) in a filing dated April 25, 2025. The proxy statement of Alnylam Pharmaceuticals, Inc. reports total compensation of $2,434,148 for Laurie B. Keating in fiscal 2020, including a base salary of $544,600. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
-
2021-01-01–2025-04-25
Last confirmed by a filing; no departure on record
-
Alnylam Pharmaceuticals, Inc. (ALNY)
Proxy statement
Start not stated–2021-04-02
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immuneering Corp
Other people whose current roles at this company are on record from its filings.
- Benjamin Zeskind CEO, Board Member
- Andrew Gengos CFO
- Biren Amin CFO
- Michael D. Bookman General Counsel, Board Member
- Mallory Morales Chief Accounting Officer, Board Member
- Brett Hall Board Member
- Harold E. Brakewood Board Member
- Igor Matushansky Board Member
- Leah R. Neufeld Board Member
- Peter Feinberg Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, ChiefLegal Officer and Secretary | $544,600 | $2,434,148 |
| 2019 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, ChiefLegal Officer and Secretary | $490,400 | $2,421,680 |
| 2018 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, ChiefLegal Officer and Secretary | $446,700 | $1,614,018 |
Recent activity
No call appearances or filed executive changes recorded yet.